Catalyst Wire Dossier Catalyst Wire Dossier

Endoscopic injection sclerosant (unspecified)

sclerosant used in endoscopic injection sclerotherapy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Endoscopic injection sclerosant (unspecified), covering 2018-04-24 to 2018-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Endoscopic Injection Sclerotherapy Versus N-butyl-2-cyanoacrylate Injection [Phase 3]

See pricing